Vaishali Pharma Ltd Financials
Company Logo

Vaishali Pharma Ltd Financial Statement

Vaishali Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue33.25
Operating Expense38.29
Net Profit-4.29
Net Profit Margin-12.90
Earning Per Share-3.17
EBIDTA-5.03
Effective Tax Rate25.79

Vaishali Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual86.28
Operating Expenses Annual85.14
Operating Profit Annual3.17
Interest Annual1.74
Depreciation0.38
Net Profit Annual0.72
Tax Annual0.21

Vaishali Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.98
Cash Flow from Operations0.81
Cash Flow from Investing1.20
Cash Flow from Financing-1.42
Cash Flow at the End1.58

Vaishali Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.29
PBIT Margin (%)3.70
PBT Margin (%)2.07
Net PROFIT Margin (%)0.83
Return On Networth / Equity (%)1.73
Return On Networth /Employed (%)5.71
Return On Assets (%)1.29
Total Debt / Equity (X)0.34
Asset Turnover Ratio (%)1.54

Vaishali Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual2.26
Total Current Assets Annual74.52
Non Current Assets Annual5.44
Total Shareholders Funds Annual42.84
Total Assets Annual79.96

Vaishali Pharma Ltd Earning Calls

No Data Availabe

FAQS on Vaishali Pharma Ltd Financials

As of Jun 7, 2025, Vaishali Pharma Ltd has a market capitalization of 134.85 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vaishali Pharma Ltd is with a debt-to-equity ratio of 0.19.

In FY 2024 , Vaishali Pharma Ltd recorded a total revenue of approximately 99.03 Cr marking a significant milestone in the company's financial performance.

Vaishali Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.2% annually, respectively..

Vaishali Pharma Ltd's current PE ratio is 164.45.

Vaishali Pharma Ltd's ROCE averaged 9.3% from the FY ending March 2023 to 2025, with a median of 4.7%. It peaked at 19.6% in March 2023, reflecting strong capital efficiency over the period..

Vaishali Pharma Ltd's latest EBIT is Rs. 2.81 Cr, surpassing the average EBIT of Rs. 5.45 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions